Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,613 | -9,458 | -6,453 | -4,442 | -1,968 |
| Depreciation Amortization | 3 | 11 | 8 | 5 | 2 |
| Accounts payable and accrued liabilities | 111 | 657 | -39 | -139 | -98 |
| Other Working Capital | -128 | 834 | -357 | -726 | -131 |
| Other Operating Activity | 319 | 638 | 970 | 704 | 341 |
| Operating Cash Flow | $-3,308 | $-7,318 | $-5,871 | $-4,598 | $-1,855 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -18 | -18 | -18 | -6 |
| Investing Cash Flow | $-4 | $-18 | $-18 | $-18 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 478 | 14,222 | N/A | N/A | N/A |
| Other Financing Activity | -130 | -88 | -45 | 0 | 0 |
| Financing Cash Flow | $347 | $14,134 | $-45 | $N/A | $N/A |
| Beginning Cash Position | 14,040 | 7,241 | 7,241 | 7,241 | 7,241 |
| End Cash Position | 11,075 | 14,040 | 1,307 | 2,626 | 5,380 |
| Net Cash Flow | $-2,964 | $6,798 | $-5,934 | $-4,616 | $-1,862 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,308 | -7,318 | -5,871 | -4,598 | -1,855 |
| Capital Expenditure | -4 | -18 | -18 | -18 | -6 |
| Free Cash Flow | -3,312 | -7,336 | -5,889 | -4,616 | -1,862 |